Ensysce Biosciences Stock Price, News & Analysis
Company Description
Ensysce Biosciences (OTC Link: ENSCW) is a publicly traded biotechnology company in the Healthcare sector.
ENSCW stock has declined 91.3% over the past year. Shares last traded at $0.0020.
On a trailing twelve-month basis, Ensysce Biosciences reported revenue of $5.1M with net income of -$10.2M and diluted earnings per share of $-3.98. The company operates at a net profit margin of -200.9%.
This page provides a comprehensive overview of ENSCW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ensysce Biosciences (ENSCW) stock last traded at $0.0020. Over the past 12 months, the stock has lost 91.3%.
ENSCW Rankings
Latest News
Ensysce Biosciences has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 8 with negative movement. Key topics include management, clinical trial, partnership. View all ENSCW news →
SEC Filings
Ensysce Biosciences has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form S-3, 2 Form 10-Q, 2 Form 10-K. The most recent filing was submitted on June 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ENSCW SEC filings →
Financial Highlights
Ensysce Biosciences generated $5.1M in revenue over the trailing twelve months, operating income reached -$10.2M (-202.1% operating margin), and net income was -$10.2M, reflecting a -200.9% net profit margin. Diluted earnings per share stood at $-3.98. The company generated -$7.8M in operating cash flow. With a current ratio of 1.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ensysce Biosciences (ENSCW) currently stands at 58.6 thousand shares, representing 2.3% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Ensysce Biosciences (ENSCW) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 71.4% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ENSCW Company Profile & Sector Positioning
Ensysce Biosciences (ENSCW) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ENSCW often look at related companies in the same sector, including Virpax Pharmaceuticals Inc (VRPX), POOLBEG PHARMA PLC (POLBF), Defence Therapeu (DTCFF), Oncotelic Therapeutics Inc (OTLC), and Preveceutical (PRVCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENSCW's relative position within its industry.